Nuvectis Pharma, Inc. NVCT Increase (Decrease) in Other Current Assets

Increase (Decrease) in Other Current Assets at other companies

PhotronicsPLAB

$2.19M+319%

Hilton WorldwideHLT

-$2.5M-100%

KEE

Keel Infrastructure Corp. Common StockKEEL

-$111K-103%

TidewaterTDW

-$517K-30.6%

Lightpath TechnologiesLPTH

$162.31K+606%

ScansourceSCSC

$11.92M+242%

Operating income-$6.3M-12.4%

Net income-$6.1M-13.5%

EPS (diluted)-$0.26+3.7%

Cash & equivalents$25.1M-15.9%

Total equity$14.2M-32.1%

Total assets$25.4M-15.8%

Operating cash flow-$6.5M-56.0%

Market cap$739.27M+335%

Return on equity-154.4%+79.4pp

Current ratio2.3×-1.0×

Reported directly by Nuvectis Pharma, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherCurrentAssets.

The official record: Nuvectis Pharma, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is Nuvectis Pharma, Inc.'s increase (decrease) in other current assets?: Nuvectis Pharma, Inc. (NVCT) reported increase (decrease) in other current assets of $193K in Q1 2026.
How has Nuvectis Pharma, Inc.'s increase (decrease) in other current assets changed year-over-year?: Nuvectis Pharma, Inc.'s increase (decrease) in other current assets decreased by 8.1% year-over-year, from $210K to $193K.